» Articles » PMID: 28646911

Autophagy and Multidrug Resistance in Cancer

Overview
Journal Chin J Cancer
Publisher Biomed Central
Specialty Oncology
Date 2017 Jun 26
PMID 28646911
Citations 345
Authors
Affiliations
Soon will be listed here.
Abstract

Multidrug resistance (MDR) occurs frequently after long-term chemotherapy, resulting in refractory cancer and tumor recurrence. Therefore, combatting MDR is an important issue. Autophagy, a self-degradative system, universally arises during the treatment of sensitive and MDR cancer. Autophagy can be a double-edged sword for MDR tumors: it participates in the development of MDR and protects cancer cells from chemotherapeutics but can also kill MDR cancer cells in which apoptosis pathways are inactive. Autophagy induced by anticancer drugs could also activate apoptosis signaling pathways in MDR cells, facilitating MDR reversal. Therefore, research on the regulation of autophagy to combat MDR is expanding and is becoming increasingly important. We summarize advanced studies of autophagy in MDR tumors, including the variable role of autophagy in MDR cancer cells.

Citing Articles

Layered Double Hydroxide LDH-Loaded miR-141-3p Targets RAB10 Suppressing Cellular Autophagy to Reverse Paclitaxel Resistance in Breast Cancer.

Tao S, Ji Y, Li R, Xiao Y, Wu H, Ye R ACS Omega. 2025; 10(6):5886-5899.

PMID: 39989842 PMC: 11840594. DOI: 10.1021/acsomega.4c09755.


New Insights into Aspirin's Anticancer Activity: The Predominant Role of Its Iron-Chelating Antioxidant Metabolites.

Kontoghiorghes G Antioxidants (Basel). 2025; 14(1).

PMID: 39857363 PMC: 11763074. DOI: 10.3390/antiox14010029.


Molecular mechanisms of mTOR-mediated cisplatin response in tumor cells.

Maharati A, Rajabloo Y, Moghbeli M Heliyon. 2025; 11(1):e41483.

PMID: 39834411 PMC: 11743095. DOI: 10.1016/j.heliyon.2024.e41483.


The role of mitochondria in aging, cell death, and tumor immunity.

Wang Q, Yuan Y, Liu J, Li C, Jiang X Front Immunol. 2025; 15:1520072.

PMID: 39763653 PMC: 11701224. DOI: 10.3389/fimmu.2024.1520072.


Role of vascular endothelium and exosomes in cancer progression and therapy (Review).

Dai Y, Yao Y, He Y, Hu X Int J Oncol. 2024; 66(1).

PMID: 39635838 PMC: 11684794. DOI: 10.3892/ijo.2024.5712.


References
1.
Anreddy N, Gupta P, Kathawala R, Patel A, Wurpel J, Chen Z . Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance. Molecules. 2014; 19(9):13848-77. PMC: 6271846. DOI: 10.3390/molecules190913848. View

2.
Pan B, Chen D, Huang J, Wang R, Feng B, Song H . HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma. Mol Cancer. 2014; 13:165. PMC: 4125709. DOI: 10.1186/1476-4598-13-165. View

3.
Wei P, Zhang L, Lu Y, Man N, Wen L . C60(Nd) nanoparticles enhance chemotherapeutic susceptibility of cancer cells by modulation of autophagy. Nanotechnology. 2010; 21(49):495101. DOI: 10.1088/0957-4484/21/49/495101. View

4.
Li X, Feng J, Zhang R, Wang J, Su T, Tian Z . Quaternized Chitosan/Alginate-Fe3O4 Magnetic Nanoparticles Enhance the Chemosensitization of Multidrug-Resistant Gastric Carcinoma by Regulating Cell Autophagy Activity in Mice. J Biomed Nanotechnol. 2016; 12(5):948-61. DOI: 10.1166/jbn.2016.2232. View

5.
Shi C, Zhang Z, Shi J, Wang F, Luan Y . Co-delivery of docetaxel and chloroquine via PEO-PPO-PCL/TPGS micelles for overcoming multidrug resistance. Int J Pharm. 2015; 495(2):932-9. DOI: 10.1016/j.ijpharm.2015.10.009. View